Press "Enter" to skip to content

Government as the First Investor in Biopharmaceutical Innovation

1
Listen to this article
Copyright © DrugPatentWatch. Originally published at Government as the First Investor in Biopharmaceutical Innovation
United States Capitol Building in Washington DC

Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government funding in recently approved drugs.

They focused on the 356 new drugs approved by the U.S. Food and Drug Administration from 2010-2019 and found:

  • Research on the 356 drugs comprised 244,000 publications, of which 39,000 were supported by NIH funding
  • NIH funding also produced 22,000 patents, which provided marketing exclusivity for 27 (8.6%) of the drugs

For more details, see the full paper at https://www.ineteconomics.org/uploads/papers/WP_133-Cleary-et-al-Govt-innovation.pdf

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at Government as the First Investor in Biopharmaceutical Innovation
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!